Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.VaxyGen Manufacturing Services has signed an exclusive license and collaboration agreement with Georgia State University Research Foundation (GSURF) to commercialize novel biological process development patent for producing proteins in biopharmaceutical and vaccine products.
Subscribe to our email newsletter
Under the terms of the collaborative agreement, VaxyGen and Georgia State University will work in the commercial development of the resident know-how and technology.
VaxyGen provides custom contract services in support of biological process optimization, scale-up and the development of manufacturing processes relative to biopharmaceutical and vaccine products.
The Georgia State University Research Foundation supports the research, technology commercialization and economic development activities of GSU.